Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Elevated IgM levels as a marker for a unique phenotype in patients with Ataxia telangiectasia.

Krauthammer A, Lahad A, Goldberg L, Sarouk I, Weiss B, Somech R, Soudack M, Pessach IM.

BMC Pediatr. 2018 Jun 4;18(1):185. doi: 10.1186/s12887-018-1156-1.

2.

Management of Stenotrophomonas maltophilia Infections in Critically Ill Children.

Tokatly Latzer I, Paret G, Rubinstein M, Keller N, Barkai G, Pessach IM.

Pediatr Infect Dis J. 2018 Oct;37(10):981-986. doi: 10.1097/INF.0000000000001959.

PMID:
29634621
3.

Somatic NRAS mutation in patient with generalized lymphatic anomaly.

Manevitz-Mendelson E, Leichner GS, Barel O, Davidi-Avrahami I, Ziv-Strasser L, Eyal E, Pessach I, Rimon U, Barzilai A, Hirshberg A, Chechekes K, Amariglio N, Rechavi G, Yaniv K, Greenberger S.

Angiogenesis. 2018 May;21(2):287-298. doi: 10.1007/s10456-018-9595-8. Epub 2018 Feb 3.

PMID:
29397482
4.

Deformation Analysis of Myocardial Layers Detects Early Cardiac Dysfunction after Chemotherapy in Bone Marrow Transplantation Patients: A Continuous and Additive Cardiotoxicity Process.

Paraskevaidis IA, Makavos G, Tsirigotis P, Psarogiannakopoulos P, Parissis J, Gkirkas K, Pessach I, Ikonomidis I.

J Am Soc Echocardiogr. 2017 Nov;30(11):1091-1102. doi: 10.1016/j.echo.2017.07.010. Epub 2017 Aug 30.

PMID:
28864152
5.

Neonatal Cervical Osteomyelitis With Bilateral Upper Limb Paresis.

Ben-Meir E, Rubinshtein M, Pessach I, Barkai G, Keller N, Hoffman C, Feldman Z, Paret G.

Pediatr Infect Dis J. 2017 Oct;36(10):1013-1015. doi: 10.1097/INF.0000000000001618.

PMID:
28430749
6.

The gastrointestinal tract: properties and role in allogeneic hematopoietic stem cell transplantation.

Pessach I, Tsirigotis P, Nagler A.

Expert Rev Hematol. 2017 Apr;10(4):315-326. doi: 10.1080/17474086.2017.1288566. Epub 2017 Feb 8. Review.

PMID:
28136133
7.

Cardiac failure in very long chain acyl-CoA dehydrogenase deficiency requiring extracorporeal membrane oxygenation (ECMO) treatment: A case report and review of the literature.

Katz S, Landau Y, Pode-Shakked B, Pessach IM, Rubinshtein M, Anikster Y, Salem Y, Paret G.

Mol Genet Metab Rep. 2016 Dec 8;10:5-7. eCollection 2017 Mar.

8.

Low-dose alemtuzumab for GvHD prevention followed by prophylactic donor lymphocyte infusions in high-risk leukemia.

Tsirigotis P, Liga M, Gkirkas K, Stamouli M, Triantafyllou E, Marangos M, Pessach I, Sarantopoulos A, Spyridis N, Spyridonidis A.

Bone Marrow Transplant. 2017 Mar;52(3):445-451. doi: 10.1038/bmt.2016.272. Epub 2016 Dec 12.

PMID:
27941776
9.

Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies.

Brauer PM, Pessach IM, Clarke E, Rowe JH, Ott de Bruin L, Lee YN, Dominguez-Brauer C, Comeau AM, Awong G, Felgentreff K, Zhang YH, Bredemeyer A, Al-Herz W, Du L, Ververs F, Kennedy M, Giliani S, Keller G, Sleckman BP, Schatz DG, Bushman FD, Notarangelo LD, Zúñiga-Pflücker JC.

Blood. 2016 Aug 11;128(6):783-93. doi: 10.1182/blood-2015-10-676304. Epub 2016 Jun 14.

10.

Wells' syndrome with a clinicopathological correlation associated with mantle-cell lymphoma.

Pessach I, Petevi K, Gkirkas K, Stamouli M, Constantinou P, Rontogianni D, Dimitriadis G, Tsirigotis P.

Leuk Lymphoma. 2016 Nov;57(11):2702-4. doi: 10.3109/10428194.2016.1157876. Epub 2016 Mar 21. No abstract available.

PMID:
26999270
11.

PICU Propofol Use, Where Do We Go From Here?

Pessach I, Paret G.

Pediatr Crit Care Med. 2016 Mar;17(3):273-5. doi: 10.1097/PCC.0000000000000648. No abstract available.

PMID:
26945206
12.

G-CSF-primed BM for allogeneic SCT: revisited.

Pessach I, Resnick I, Shimoni A, Nagler A.

Bone Marrow Transplant. 2015 Jul;50(7):892-8. doi: 10.1038/bmt.2015.25. Epub 2015 Mar 2. Review.

PMID:
25730185
13.

Thymic and bone marrow output in individuals with 22q11.2 deletion syndrome.

Dar N, Gothelf D, Korn D, Frisch A, Weizman A, Michaelovsky E, Carmel M, Yeshayahu Y, Dubnov-Raz G, Pessach IM, Simon AJ, Lev A, Somech R.

Pediatr Res. 2015 Apr;77(4):579-85. doi: 10.1038/pr.2015.14. Epub 2015 Jan 12.

PMID:
25580739
14.

Immunohistochemical expression of cell cycle proteins in multiple myeloma.

Pessach I, Papoudou-Bai A, Goussia A, Kamina S, Kyrtsonis MC, Bourantas KL, Kanavaros P.

Leuk Lymphoma. 2015;56(9):2720-3. doi: 10.3109/10428194.2015.1004171. Epub 2015 Feb 4. No abstract available.

PMID:
25573203
15.

Glutaric Aciduria type I and acute renal failure - Coincidence or causality?

Pode-Shakked B, Marek-Yagel D, Rubinshtein M, Pessach IM, Paret G, Volkov A, Anikster Y, Lotan D.

Mol Genet Metab Rep. 2014 Apr 17;1:170-175. eCollection 2014.

16.

Assessment of bortezomib induced peripheral neuropathy in multiple myeloma by the reduced Total Neuropathy Score.

Zaroulis CK, Chairopoulos K, Sachanas SP, Maltezas D, Tzenou T, Pessach I, Koulieris E, Koutra E, Kilindireas K, Pangalis GA, Kyrtsonis MC.

Leuk Lymphoma. 2014 Oct;55(10):2277-83. doi: 10.3109/10428194.2013.873535. Epub 2014 Mar 19.

PMID:
24552516
17.

Genetic variation in schlafen genes in a patient with a recapitulation of the murine Elektra phenotype.

Recher M, Karjalainen-Lindsberg ML, Lindlöf M, Söderlund-Venermo M, Lanzi G, Väisänen E, Kumar A, Sadeghi M, Berger CT, Alitalo T, Anttila P, Kolehmainen M, Franssila R, Chen T, Siitonen S, Delmonte OM, Walter JE, Pessach I, Hess C, Simpson MA, Navarini AA, Giliani S, Hedman K, Seppänen M, Notarangelo LD.

J Allergy Clin Immunol. 2014 May;133(5):1462-5, 1465.e1-5. doi: 10.1016/j.jaci.2013.10.052. Epub 2013 Dec 24. No abstract available.

PMID:
24373355
18.

OCT1 genetic variants are associated with long term outcomes in imatinib treated chronic myeloid leukemia patients.

Koren-Michowitz M, Buzaglo Z, Ribakovsky E, Schwarz M, Pessach I, Shimoni A, Beider K, Amariglio N, le Coutre P, Nagler A.

Eur J Haematol. 2014 Apr;92(4):283-8. doi: 10.1111/ejh.12235. Epub 2013 Dec 18.

PMID:
24215657
19.

Pediatric out-of-hospital cardiac arrest-are we behind the times?*.

Pessach IM, Paret G.

Pediatr Crit Care Med. 2013 Oct;14(8):821-2. doi: 10.1097/PCC.0000000000000013. No abstract available.

PMID:
24096689
20.

Granulocyte-colony stimulating factor for hematopoietic stem cell donation from healthy female donors during pregnancy and lactation: what do we know?

Pessach I, Shimoni A, Nagler A.

Hum Reprod Update. 2013 May-Jun;19(3):259-67. doi: 10.1093/humupd/dms053. Epub 2013 Jan 3. Review.

PMID:
23287427
21.

Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells.

Lafaille FG, Pessach IM, Zhang SY, Ciancanelli MJ, Herman M, Abhyankar A, Ying SW, Keros S, Goldstein PA, Mostoslavsky G, Ordovas-Montanes J, Jouanguy E, Plancoulaine S, Tu E, Elkabetz Y, Al-Muhsen S, Tardieu M, Schlaeger TM, Daley GQ, Abel L, Casanova JL, Studer L, Notarangelo LD.

Nature. 2012 Nov 29;491(7426):769-73. doi: 10.1038/nature11583. Epub 2012 Oct 28.

22.

Apoptotic cells in allogeneic hematopoietic stem cell transplantations: "turning trash into gold".

Pessach I, Shimoni A, Nagler A.

Leuk Lymphoma. 2012 Nov;53(11):2130-5. doi: 10.3109/10428194.2012.690099. Review.

PMID:
22553946
23.

A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP.

Lanzi G, Moratto D, Vairo D, Masneri S, Delmonte O, Paganini T, Parolini S, Tabellini G, Mazza C, Savoldi G, Montin D, Martino S, Tovo P, Pessach IM, Massaad MJ, Ramesh N, Porta F, Plebani A, Notarangelo LD, Geha RS, Giliani S.

J Exp Med. 2012 Jan 16;209(1):29-34. doi: 10.1084/jem.20110896. Epub 2012 Jan 9.

24.

Looking into the crystal ball: can we predict prognosis in children treated with therapeutic hypothermia after cardiac arrest?.

Pessach IM, Paret G.

Pediatr Crit Care Med. 2012 Jan;13(1):97-8. doi: 10.1097/PCC.0b013e318223125a. No abstract available.

PMID:
22222645
25.

Primary immunodeficiency modeling with induced pluripotent stem cells.

Pessach IM, Notarangelo LD.

Curr Opin Allergy Clin Immunol. 2011 Dec;11(6):505-11. doi: 10.1097/ACI.0b013e32834cb943. Review.

PMID:
22001741
26.

Development of acute myeloid leukemia with NPM1 mutation, in Ph-negative clone, during treatment of CML with imatinib.

Georgiou G, Efthymiou A, Vardounioti I, Boutsikas G, Angelopoulou MK, Vassilakopoulos TP, Kyrtsonis MC, Plata E, Tofas P, Bitsani A, Bartzi V, Pessach I, Dimou M, Panayiotidis P.

Leukemia. 2012 Apr;26(4):824-6. doi: 10.1038/leu.2011.280. Epub 2011 Oct 11. No abstract available.

PMID:
21986839
27.

Reduced thymic output, cell cycle abnormalities, and increased apoptosis of T lymphocytes in patients with cartilage-hair hypoplasia.

de la Fuente MA, Recher M, Rider NL, Strauss KA, Morton DH, Adair M, Bonilla FA, Ochs HD, Gelfand EW, Pessach IM, Walter JE, King A, Giliani S, Pai SY, Notarangelo LD.

J Allergy Clin Immunol. 2011 Jul;128(1):139-146. doi: 10.1016/j.jaci.2011.03.042. Epub 2011 May 13.

28.

Gene therapy for primary immunodeficiencies: looking ahead, toward gene correction.

Pessach IM, Notarangelo LD.

J Allergy Clin Immunol. 2011 Jun;127(6):1344-50. doi: 10.1016/j.jaci.2011.02.027. Epub 2011 Mar 25. Review.

29.

Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies.

Pessach IM, Ordovas-Montanes J, Zhang SY, Casanova JL, Giliani S, Gennery AR, Al-Herz W, Manos PD, Schlaeger TM, Park IH, Rucci F, Agarwal S, Mostoslavsky G, Daley GQ, Notarangelo LD.

J Allergy Clin Immunol. 2011 Jun;127(6):1400-7.e4. doi: 10.1016/j.jaci.2010.11.008. Epub 2010 Dec 24.

30.

Carina angle measurements for diagnosis of patent ductus arteriosus in preterm infants.

Strauss T, Pessach I, Jacoby E, Schushan-Eisen I, Mazkereth R, Kuint J.

Neonatology. 2011;99(3):224-30. doi: 10.1159/000315862. Epub 2010 Sep 29.

PMID:
20881439
31.

The relationship of x-linked primary immune deficiencies and autoimmunity.

Pessach IM.

Curr Allergy Asthma Rep. 2010 Sep;10(5):311-9. doi: 10.1007/s11882-010-0127-x. Review.

PMID:
20571932
32.

Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency.

Walter JE, Rucci F, Patrizi L, Recher M, Regenass S, Paganini T, Keszei M, Pessach I, Lang PA, Poliani PL, Giliani S, Al-Herz W, Cowan MJ, Puck JM, Bleesing J, Niehues T, Schuetz C, Malech H, DeRavin SS, Facchetti F, Gennery AR, Andersson E, Kamani NR, Sekiguchi J, Alenezi HM, Chinen J, Dbaibo G, ElGhazali G, Fontana A, Pasic S, Detre C, Terhorst C, Alt FW, Notarangelo LD.

J Exp Med. 2010 Jul 5;207(7):1541-54. doi: 10.1084/jem.20091927. Epub 2010 Jun 14.

33.

Sublingual desensitization for buprenorphine hypersensitivity.

Stutius LM, Pessach I, Lee J, Lo MS, Levy S, Schram P, Schizer M, Wong J, Phipatanakul W, Umetsu DT.

J Allergy Clin Immunol. 2010 Apr;125(4):938-9. doi: 10.1016/j.jaci.2009.12.982. Epub 2010 Mar 11. No abstract available.

34.

Analysis of circulating hem-endothelial marker RNA levels in preterm infants.

Strauss T, Metsuyanim S, Pessach I, Shuchan-Eisen I, Kuint J, Dekel B.

BMC Pediatr. 2009 Jun 25;9:42. doi: 10.1186/1471-2431-9-42.

35.

X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity.

Pessach IM, Notarangelo LD.

J Autoimmun. 2009 Aug;33(1):17-24. doi: 10.1016/j.jaut.2009.03.003. Epub 2009 Apr 9. Review.

PMID:
19361956
36.

Recent advances in primary immunodeficiencies: identification of novel genetic defects and unanticipated phenotypes.

Pessach I, Walter J, Notarangelo LD.

Pediatr Res. 2009 May;65(5 Pt 2):3R-12R. doi: 10.1203/PDR.0b013e31819dbe1e.

PMID:
19190530
37.

Out of breath: GM-CSFRalpha mutations disrupt surfactant homeostasis.

Notarangelo LD, Pessach I.

J Exp Med. 2008 Nov 24;205(12):2693-7. doi: 10.1084/jem.20082378. Epub 2008 Nov 17.

38.

Suprasellar and intrasellar paragangliomas.

Voulgaris SG, Partheni M, Tzortzidis F, Ravazoula P, Pessach IS, Papadakis N, Polyzoidis KS.

Clin Neuropathol. 2006 Sep-Oct;25(5):221-6.

PMID:
17007444
40.

Early cerebral monitoring using the transcranial Doppler pulsatility index in patients with severe brain trauma.

Voulgaris SG, Partheni M, Kaliora H, Haftouras N, Pessach IS, Polyzoidis KS.

Med Sci Monit. 2005 Feb;11(2):CR49-52.

PMID:
15668630
41.

Risk of venous thromboembolism in pediatric patients with brain tumors.

Tabori U, Beni-Adani L, Dvir R, Burstein Y, Feldman Z, Pessach I, Rechavi G, Constantini S, Toren A.

Pediatr Blood Cancer. 2004 Nov;43(6):633-6.

PMID:
15390288
42.

Teaching medical students what they think they already know.

Fadlon J, Pessach I, Toker A.

Educ Health (Abingdon). 2004 Mar;17(1):35-41.

PMID:
15203472
43.

Cytosolic phospholipase A2 is responsible for prostaglandin E2 and leukotriene B4 formation in phagocyte-like PLB-985 cells: studies of differentiated cPLA2-deficient PLB-985 cells.

Liberty IF, Raichel L, Hazan-Eitan Z, Pessach I, Hadad N, Schlaeffer F, Levy R.

J Leukoc Biol. 2004 Jul;76(1):176-84. Epub 2004 May 3.

PMID:
15123778
44.

Unique targeting of cytosolic phospholipase A2 to plasma membranes mediated by the NADPH oxidase in phagocytes.

Shmelzer Z, Haddad N, Admon E, Pessach I, Leto TL, Eitan-Hazan Z, Hershfinkel M, Levy R.

J Cell Biol. 2003 Aug 18;162(4):683-92. Epub 2003 Aug 11.

45.
46.
47.

[The influence of human and cow's milk on cholesterol and cholesterol ester levels and on the lipid pattern in the blood infants].

GOTLIEB A, ABRAMOV M, SCHWARTZ M, PESSACH I.

Harefuah. 1960 Jan 15;58:43-5. Hebrew. No abstract available.

PMID:
13851414

Supplemental Content

Loading ...
Support Center